Skip to content

CPHI CHINA PHARMA HLDGS INC

Follow

COM SHS (common), issuer CIK 1106644

5 managers (5 13F filers) reported a position in CPHI shares at 2025-09-30, 60,276 shares in all. 2 filers opened a position and 2 filers sold out during the quarter.

Managers
5
13F filers
5
New
2
Added
1
Reduced
1
Sold out
2
Shares held by filers
60,276

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC30,426$59.3K<0.01%+7,35613F-HRTimelineGroup
UBS Group AGin group UBS Group AG19,191$37.4K<0.01%-52,04213F-HRTimelineGroup
RENAISSANCE TECHNOLOGIES LLC10,618$20.7K<0.01%new13F-HRTimeline
JPMORGAN CHASE & COin group JPMORGAN CHASE & CO40$78<0.01%new13F-HR/ATimelineGroup
DANSKE BANK A/S1$2<0.01%013F-HR/ATimeline